QUYCHI H LE
Allopathic & Osteopathic Physicians|General Practice BLUE SPRINGS, MO NPI 1366738445
Browse related groups: Allopathic & Osteopathic Physicians|General Practice MO Merck Sharp & Dohme Corporation All categories
General Payments — all program years on this page
$159.82
- Category: General Payments
- Program years: PY2019
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $159.82 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $159.82 | 8 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $69.34 | 1 |
| Amgen Inc. | $27.00 | 2 |
| Novo Nordisk AS | $26.34 | 2 |
| Allergan Inc. | $13.95 | 1 |
| Janssen Pharmaceuticals, Inc | $12.30 | 1 |
| Teva Pharmaceuticals USA, Inc. | $10.89 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2019 | $159.82 | 8 |
Records — PY2019 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 658899887 | Janssen Pharmaceuticals, Inc | $12.30 | 02/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 662887941 | Amgen Inc. | $12.99 | 03/25/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 662887945 | Amgen Inc. | $14.01 | 05/06/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 668766335 | Novo Nordisk Inc | $14.55 | 02/18/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 670706657 | Allergan Inc. | $13.95 | 03/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 674489349 | Novo Nordisk Inc | $11.79 | 07/08/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 695413891 | Merck Sharp & Dohme Corporation | $69.34 | 02/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 697786125 | Teva Pharmaceuticals USA, Inc. | $10.89 | 01/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.